Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07052344 · ClinicalTrials.gov registry record · NA
Gut-Brain Neural Coupling in Spinal Cord Injury
A NA study of SCI - Spinal Cord Injury, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT07052344: Recruiting NA study of SCI - Spinal Cord Injury, sponsored by University of Miami.
NCT07052344 is a NA study of SCI - Spinal Cord Injury that is actively recruiting participants, run by University of Miami. The registered enrollment target is 28 participants, below the 36-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07052344, a NA study of SCI - Spinal Cord Injury, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the effects of food on brain and stomach activity in persons with and without spinal cord injury (SCI).
Primary Outcome
Gut-brain connectivity will be assessed using phase-amplitude coupling (PAC) to examine the interaction between gastric electrical oscillations and cortical rhythms. PAC will be calculated from electrophysiological raw data to produce one unitless value ranging from -1 to 1, for each subject. The higher the value, the greater the gut-brain connectivity/PAC strength.
Conditions Studied
Interventions
- OTHER Preload condition
- OTHER Ad-libitum control condition
Study Locations (1)
Florida
- University of Miami - Miami Project to Cure Paralysis - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-10-29 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07052344 shows while recruiting
NCT07052344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 36-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (22% lower).
The record links to 1 condition, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Preload condition is the first listed.
NCT07052344 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07052344 about?
NCT07052344 is a clinical study titled "Gut-Brain Neural Coupling in Spinal Cord Injury". The purpose of this research is to determine the effects of food on brain and stomach activity in persons with and without spinal cord injury (SCI).
What is the current status of trial NCT07052344?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2025-10-29. Estimated completion is 2026-12-31.
What conditions does trial NCT07052344 study?
This clinical trial studies the following conditions: SCI - Spinal Cord Injury.
What interventions are being tested in trial NCT07052344?
The interventions under investigation include: Preload condition (OTHER), Ad-libitum control condition (OTHER).
Who is sponsoring clinical trial NCT07052344?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07052344 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SCI - Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07052344's enrollment target sits among peer trials
28 7th of 13 higher than 7 of 13 other SCI - Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other SCI - Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI
RECRUITING · NA
-
TPAD for Recovery of Standing After Severe SCI
RECRUITING · NA
-
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
RECRUITING · NA
-
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
RECRUITING · NA
-
ECoG BMI for Motor and Speech Control
RECRUITING · NA
-
Improving Balance After Spinal Cord Injury Using a Robotic Upright Stand Trainer and Spinal Cord Epidural Stimulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI